Aurora Cannabis (ACB) Depreciation & Amortization (IS) (2017 - 2025)
Aurora Cannabis (ACB) reported Depreciation & Amortization (IS) of $1.9 million for Q4 2025, down 68.82% year-over-year from $6.0 million in Q4 2024, and down 10.71% quarter-over-quarter from $2.1 million in Q3 2025.
Aurora Cannabis (ACB) Depreciation & Amortization (IS) (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Depreciation & Amortization (IS) data on file, last reported at $1.9 million in Q4 2025.
- Depreciation & Amortization (IS) for Q4 2025 came in at $1.9 million, down 68.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.9 million (down 55.88% YoY), and the FY2025 annual result was $6.3 million, down 80.27% from the prior year.
- Depreciation & Amortization (IS) retreated to $1.9 million in Q4 2025 per ACB's latest filing, from $2.1 million in the prior quarter.
- Over five years, Depreciation & Amortization (IS) peaked at $23.0 million in Q2 2021 and troughed at $1.2 million in Q2 2025.
- A 5-year average of $7.8 million and a median of $5.4 million in 2022 frame the typical range for Depreciation & Amortization (IS).
- The sharpest annual moves came in 2021 and 2022: Depreciation & Amortization (IS) jumped 130.7% in 2021, then sank 87.85% in 2022.
- A 5-year view of Depreciation & Amortization (IS) shows it stood at $10.1 million in 2021, then plunged by 53.06% to $4.7 million in 2022, then soared by 78.14% to $8.4 million in 2023, then slipped by 28.31% to $6.0 million in 2024, then plunged by 68.82% to $1.9 million in 2025.
- Business Quant data shows ACB's Depreciation & Amortization (IS) at $1.9 million in Q4 2025, $2.1 million in Q3 2025, and $1.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 1.88 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 6.03 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 6.30 Mn |
| Dec 31, 2023 | 8.41 Mn |
| Sep 30, 2023 | 2.99 Mn |
| Dec 31, 2022 | 4.72 Mn |
| Sep 30, 2022 | 2.63 Mn |
| Jun 30, 2022 | 9.11 Mn |
| Mar 31, 2022 | 18.65 Mn |
| Dec 31, 2021 | 10.06 Mn |
| Sep 30, 2021 | 21.63 Mn |
| Jun 30, 2021 | 22.96 Mn |
| Mar 31, 2021 | 17.21 Mn |
| Dec 31, 2020 | 24.46 Mn |
| Sep 30, 2020 | 16.85 Mn |